Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Aki Katamine"'
Autor:
Junko Oya, Tomoko Nakagami, Yuichiro Kondo, Aki Katamine, Mika Shimizu, Yukiko Hasegawa, Tetsuya Babazono
Publikováno v:
Tokyo Women's Medical University Journal, Vol 7, Iss 0, Pp 101-108 (2023)
Background: To compare the efficacy and safety of pemafibrate with those of fenofibrate in a real-world setting in patients with hypertriglyceridemia and type 2 diabetes (T2D). Methods: This study included 155 patients with hypertriglyceridemia (>175
Externí odkaz:
https://doaj.org/article/bac49c7903e849349bd63c2e7efbf13e
Autor:
Yukiko Hasegawa, Tomoko Nakagami, Junko Oya, Aki Katamine, Yuichiro Kondo, Ran Yoshimura, Tetsuya Babazono
Publikováno v:
Tokyo Women's Medical University Journal, Vol 7, Iss 0, Pp 75-81 (2023)
Background: Statins are effective in reducing cardiovascular events. However, statin-associated adverse muscle events, often associated with falls, remain a concern. We investigated the association between statin use and risk of falls in older indivi
Externí odkaz:
https://doaj.org/article/59969329b14d445ca715cf7e53d6ad22
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 11, Pp 1983-1991 (2021)
Abstract Aims/Introduction To evaluate and compare the efficacy of insulin degludec (IDeg) and insulin glargine 300 U/mL (Gla300) 6 months after switching from other basal insulins by assessing the changes in glycated hemoglobin (HbA1c), body mass in
Externí odkaz:
https://doaj.org/article/33e2f17798204034beea375b21f2d506
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 11, Pp 1983-1991 (2021)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction To evaluate and compare the efficacy of insulin degludec (IDeg) and insulin glargine 300 U/mL (Gla300) 6 months after switching from other basal insulins by assessing the changes in glycated hemoglobin (HbA1c), body mass index (BMI)
Autor:
Junko Oya, Tomoko Nakagami, Yuichiro Kondo, Aki Katamine, Mika Shimizu, Yukiko Hasegawa, Tetsuya Babazono
Purpose To evaluate and compare the efficacy and safety of pemafibrate, a selective peroxisome proliferator-activator α modulator, with fenofibrate and bezafibrate, classical fibrates, in a real-world setting in patients with hypertriglyceridemia an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60ae9ef379dd19545f8a7d30af1cf133
https://doi.org/10.21203/rs.3.rs-1683532/v1
https://doi.org/10.21203/rs.3.rs-1683532/v1
Autor:
Junko Oya, Ran Yoshimura, Yukiko Hasegawa, Tomoko Nakagami, Junnosuke Miura, Yuichiro Kondo, Tetsuya Babazono, Naoki Hirota, Arata Ito, Reika Tsuzura, Yasuko Uchigata, Aki Katamine
Publikováno v:
Diabetes. 67
Background: Sexual dysfunction affects the quality of life and is related to mortality among patients with diabetes (DM). The aim of the study was to assess the prevalence of erectile dysfunction (ED) and ejaculation disorder (EJD) and their related
Autor:
Oya, Junko, Nakagami, Tomoko, Hasegawa, Yukiko, Kondo, Yuichiro, Katamine, Aki, Shimizu, Mika, Kubota, Ryo, Suda, Rika, Babazono, Tetsuya
Publikováno v:
Diabetology International; Apr2024, Vol. 15 Issue 2, p237-243, 7p
Autor:
Yoshimura, Ran1 (AUTHOR), Nakagami, Tomoko1 (AUTHOR) nakagami.dmc@twmu.ac.jp, Hasegawa, Yukiko1 (AUTHOR), Oya, Junko1 (AUTHOR), Babazono, Tetsuya1 (AUTHOR)
Publikováno v:
Journal of Diabetes Investigation. Sep2022, Vol. 13 Issue 9, p1560-1566. 7p.
Autor:
Oya, Junko1 (AUTHOR) johya.dmc@twmu.ac.jp, Nakagami, Tomoko1 (AUTHOR), Hasegawa, Yukiko1 (AUTHOR), Katamine, Aki1 (AUTHOR), Kondo, Yuichiro1 (AUTHOR), Babazono, Tetsuya1 (AUTHOR)
Publikováno v:
Journal of Diabetes Investigation. Nov2021, Vol. 12 Issue 11, p1983-1991. 9p.
Publikováno v:
Diabetes Week; 1/8/2024, p273-273, 1p